Raia Drogasil SA
OTC:RADLY

Watchlist Manager
Raia Drogasil SA Logo
Raia Drogasil SA
OTC:RADLY
Watchlist
Price: 4.704 USD 1.03% Market Closed
Market Cap: 8.1B USD

Net Margin

3%
Current
Declining
by 0.1%
vs 3-y average of 3.1%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
3%
=
Net Income
R$1.2B
/
Revenue
R$41B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
3%
=
Net Income
$1.2B
/
Revenue
R$41B

Peer Comparison

Country Company Market Cap Net
Margin
BR
Raia Drogasil SA
BOVESPA:RADL3
42.8B BRL
Loading...
ZA
Clicks Group Ltd
JSE:CLS
86.3B Zac
Loading...
ZA
Dis-Chem Pharmacies Ltd
JSE:DCP
30.5B Zac
Loading...
US
Walgreens Boots Alliance Inc
NASDAQ:WBA
10.4B USD
Loading...
JP
Tsuruha Holdings Inc
TSE:3391
1.2T JPY
Loading...
JP
MatsukiyoCocokara & Co
TSE:3088
1T JPY
Loading...
JP
Sugi Holdings Co Ltd
TSE:7649
712.7B JPY
Loading...
SA
Al Nahdi Medical Company SCJSC
SAU:4164
16.8B SAR
Loading...
JP
Welcia Holdings Co Ltd
TSE:3141
657.7B JPY
Loading...
CN
Yifeng Pharmacy Chain Co Ltd
SSE:603939
27B CNY
Loading...
JP
Cosmos Pharmaceutical Corp
TSE:3349
558.5B JPY
Loading...
No Stocks Found

Market Distribution

In line with most companies in Brazil
Percentile
32nd
Based on 634 companies
32nd percentile
3%
Low
-6 965.9% — 2.1%
Typical Range
2.1% — 15.5%
High
15.5% — 1 493%
Distribution Statistics
Brazil
Min -6 965.9%
30th Percentile 2.1%
Median 8.9%
70th Percentile 15.5%
Max 1 493%

Raia Drogasil SA
Glance View

Market Cap
8.1B USD
Industry
Retail

Raia Drogasil SA, Brazil's pharmaceutical titan, stands as a testament to the transformative power of strategic mergers and innovative retail management. Born out of the merger of Drogasil and Droga Raia, two of Brazil's enduring pharmacy chains, the company today operates an extensive network of retail stores across the nation. This strategic merger in 2011 was not merely a consolidation of operations but a fusion of distinct corporate cultures and expertise, aimed at enhancing operational efficiencies and expanding market share. By leveraging economies of scale, Raia Drogasil has entrenched itself as a formidable force in Brazil's healthcare retail sector, boasting a strong presence in both high-density urban centers and emerging markets in Brazil. The company's business model is built on a robust mix of health and wellness products, encompassing everything from prescription medications to over-the-counter remedies and personal care items. Raia Drogasil has adeptly positioned itself to capitalize on Brazil's growing healthcare demands, thanks to its comprehensive product offerings and strategic store locations. Each store functions as both a destination for health-conscious consumers and a vital link in the greater logistical chain that ensures timely product availability. By intertwining brick-and-mortar retail with digital innovation, Raia Drogasil not only drives revenue through traditional sales channels but also through its dynamic e-commerce platform. This synergy allows the company to tap into the evolving preferences of tech-savvy consumers, thereby making Raia Drogasil a leader in seamlessly integrating shopping experiences that cater to modern customer expectations.

RADLY Intrinsic Value
3.869 USD
Overvaluation 18%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
3%
=
Net Income
R$1.2B
/
Revenue
R$41B
What is Raia Drogasil SA's current Net Margin?

The current Net Margin for Raia Drogasil SA is 3%, which is below its 3-year median of 3.1%.

How has Net Margin changed over time?

Over the last 3 years, Raia Drogasil SA’s Net Margin has decreased from 3.1% to 3%. During this period, it reached a low of 2.9% on Jun 30, 2024 and a high of 3.4% on Mar 31, 2023.

Back to Top